Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
Β 

ORYX INTERNATIONAL GROWTH FUND LIMITED

Β INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

Β Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

Β This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

Β This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

Β Manager's Review

During the period under review, the FTSE Small Cap TR (Β£) Index returned -4.24% and the FTSE All-Share TR Index (Β£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

Β The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

Β Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

Β 24 April 2012 a total of 379,653 ordinary shares at a gross price of Β£2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

Β Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

Β 

Β 

30 June 2012Β 

31 MarchΒ 2012Β 

31 DecemberΒ 2011Β 

30 SeptemberΒ 2011Β 

30 JuneΒ 2011Β 

Β 

Β 

Β 

Β 

Β 

Β 

NAV

Β£2.93

Β£3.03

Β£2.79

Β£2.69

Β£2.96

Β 

Β 

Β 

Β 

Β 

Β 

US Dollar / Sterling Exchange Rate

Β 

1.5685

Β 

1.5978

Β 

1.5541

Β 

1.5579

Β 

1.6055

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Twenty Largest Equity Investments at 30 June 2012

Β 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

Β 

Β 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

Β 

By order of the Board

Β 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSGGUCPRUPPGUQ
Date   Source Headline
1st Jun 20114:27 pmRNSNet Asset Value(s)
27th May 20119:11 amRNSTransaction in Own Shares
18th Apr 201111:30 amRNSHolding(s) in Company
15th Apr 20115:12 pmRNSTransaction in Own Shares
13th Apr 20114:00 pmRNSNet Asset Value(s)
13th Apr 20111:05 pmRNSListing Rule 15.5.1(4)
16th Mar 20116:00 pmRNSNet Asset Value(s)
10th Mar 20112:30 pmRNSHolding(s) in Company
9th Mar 20116:20 pmRNSDirectorate Change
9th Mar 20115:11 pmRNSHolding(s) in Company
9th Mar 20115:10 pmRNSHolding(s) in Company
28th Feb 20114:30 pmRNSNet Asset Value(s)
16th Feb 201110:53 amRNSForm 8.3 - IS Pharma Plc
10th Feb 20114:30 pmRNSInterim Management Statement
1st Feb 201111:30 amRNSNet Asset Value(s)
24th Dec 20109:45 amRNSNet Asset Value(s)
13th Dec 20109:54 amRNSTransaction in Own Shares
3rd Dec 201012:10 pmRNSDirectorate Change
2nd Dec 20104:23 pmRNSNet Asset Value(s)
1st Dec 20105:15 pmRNSPosting of Half Year report
19th Nov 20105:50 pmRNSTransaction in Own Shares
19th Nov 20103:09 pmRNSChange of Financial Adviser and Broker
16th Nov 201010:55 amRNSTransaction in Own Shares
11th Nov 20106:31 pmRNSHalf Yearly Report
21st Oct 20101:20 pmRNSNet Asset Value(s) - Replacement
21st Oct 20101:20 pmRNSNet Asset Value(s) - Replacement
20th Oct 20103:55 pmRNSNet Asset Value(s)
20th Oct 20103:55 pmRNSNet Asset Value(s)
1st Oct 20102:22 pmRNSTransactions in Close Period
30th Sep 20101:12 pmRNSNet Asset Value(s)
23rd Aug 20105:28 pmRNSTransaction in Own Shares
23rd Aug 201010:26 amRNSHolding(s) in Company
20th Aug 201011:17 amRNSResult of AGM
19th Aug 20105:38 pmRNSInterim Management Statement
18th Aug 20103:55 pmRNSNet Asset Value(s)
19th Jul 201010:15 amRNSNet Asset Value(s)
16th Jul 20109:17 amRNSHolding(s) in Company
5th Jul 20103:54 pmRNSCirc re. AGM, proposed waiver and change Articles
25th Jun 20103:48 pmRNSNet Asset Value(s)
23rd Jun 20107:00 amRNSAnnual Financial Report
16th Jun 20104:09 pmRNSTransaction in Own Shares
16th Jun 20104:01 pmRNSHolding(s) in Company
10th Jun 20104:57 pmRNSNet Asset Value(s)
21st Apr 20103:33 pmRNSChange of Auditors
21st Apr 20102:57 pmRNSNet Asset Value(s)
15th Apr 20103:28 pmRNSTransactions in a Closed Period
26th Mar 201011:12 amRNSHolding(s) in Company
26th Mar 20107:00 amRNSHolding(s) in Company
18th Mar 20103:53 pmRNSTransaction in Own Shares
17th Mar 201010:15 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.